Stand up to cancer initiatives partnered with global payment networks to channel donor support into accelerated cancer research and patient services. Mastercard leverages its transaction infrastructure and corporate giving programs to fund breakthrough science and improve care access.
Through co-branded campaigns and employee engagement, the alliance emphasizes measurable outcomes and transparent reporting for every funded project.
| Partner | Program Focus | Funding Mechanism | Impact Metric |
|---|---|---|---|
| Stand Up To Cancer | Innovative translational research | Campaign donations & pledges | Research milestones reached |
| Mastercard | Employee giving and matching gifts | Corporate contributions and payroll giving | Employee participation rate |
| Research institutions | Clinical trials and data platforms | Grant awards from pooled campaign funds | Patients enrolled and therapies advanced |
| Healthcare providers | Access improvements and support services | Program-funded service expansions | Care completion and patient outcomes |
Research Funding Priorities
Aligned initiatives identify high-potential research projects that can move from lab to clinic quickly under the stand up to cancer and Mastercard partnership.
Targeted Therapy Acceleration
Focused grants support biomarker-driven approaches and next-generation immunotherapies with clear development timelines.
Data Sharing and Collaboration
Standardized datasets and open science principles enable cross-institutional studies that reduce duplication and speed insights.
Employee Engagement and Giving
Mastercard runs internal campaigns that match employee donations and spotlight personal stories to deepen engagement.
- Company match programs double individual impact
- Volunteer hours connect staff with research partners
- Transparent dashboards show funded milestones
- Recognition highlights teams that participate
Program Impact and Outcomes
Tracking outcomes helps demonstrate how stand up to cancer and Mastercard collaborations translate donations into patient benefit.
| Outcome Area | 2022 | 2023 | 2024 Target |
|---|---|---|---|
| Research projects funded | 28 | 35 | 42 |
| Patients enrolled in trial support | 4,200 | 5,600 | 7,000 |
| Employee participants | 8,500 | 10,200 | 12,000 |
| Countries with active partnerships | 6 | 9 | 11 |
Partnership with Healthcare Providers
Healthcare institutions coordinate care pathways and implement protocols funded through stand up to cancer and Mastercard pooled resources.
Access and Navigation Services
Dedicated navigation teams help patients find trials, manage appointments, and handle insurance complexities.
Clinical Trial Capacity
Expanded site capabilities shorten enrollment timelines and improve geographic representation in studies.
Innovation and Technology
Digital tools and analytics platforms enable faster decision-making and more efficient allocation of campaign resources.
- Real-time dashboards track funds disbursed and milestones achieved
- Predictive models highlight promising research trajectories
- Secure data pipelines protect patient privacy while enabling collaboration
- Cloud infrastructure scales to handle surge campaign periods
FAQ
How do Mastercard employee donations get matched to stand up to cancer programs?
Mastercard multiplies individual gifts through company match, directing increased funds to vetted research and patient support initiatives administered by partner institutions.
What types of cancer research are prioritized in the joint programs?
Priority areas include translational projects that can advance quickly into clinical trials, with an emphasis on therapies targeting underserved populations.
Can donors see how their stand up to cancer contributions are used through Mastercard platforms?
Donors receive periodic impact reports outlining funded projects, milestone progress, and outcome indicators aligned with campaign goals.
How are patient outcomes measured across funded initiatives?
Outcomes are evaluated using standardized metrics such as enrollment numbers, survival indicators, and quality-of-life data shared by research partners.
Future Direction and Collaboration
Ongoing refinement of programs, guided by independent evaluation, will shape how stand up to cancer and Mastercard continue to drive meaningful progress in cancer care and research.
- Expand research funding to emerging therapeutic areas
- Grow employee participation and local community engagement
- Strengthen data transparency and outcome reporting
- Deepen partnerships with healthcare systems worldwide
